- Medical - Devices
- Healthcare
Medtronic plc
MDT · IE ·
NYSE
81.51
USD
+1.02
(1.25%)
-
2.78
EPS
-
29.32
P/E
-
105B
MARKET CAP
-
3.40%
DIV YIELD
Executives
Name | Title | Pay |
---|---|---|
Ms. Jennifer M. Kirk | Senior Vice President, Global Controller & Chief Accounting Officer | -- |
Dr. Laura Mauri M.D., M.Sc. | Senior Vice President and Chief Scientific & Medical Officer | -- |
Mr. Torod B. Neptune | Senior Vice President & Chief Communications Officer | -- |
Mr. Ryan Weispfenning | Vice President & Head of Investor Relations | -- |
Mr. Sean M. Salmon | Executive Vice President & President of Cardiovascular Portfolio | 901K |
Mr. Matt Walter | Chief Human Resources Officer | -- |
Dr. Kenneth E. Washington Ph.D. | Senior Vice President and Chief Technology & Innovation Officer | -- |
Mr. Ivan K. Fong | Executive Vice President, General Counsel & Secretary | 986K |
Mr. Mark Ploof | Senior Vice President of Global Operations and Business Services | -- |
Mr. Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer | 1.79M |
Insider Transactions
Date | Name | Title | Acquisition Or Disposition | Stock / Options | # of Shares | Price |
---|---|---|---|---|---|---|
2024-07-31 | Smith Gregory L | EVP Global Ops & Supply Chain | D - F-InKind | Ordinary Shares | 1406 | 80.32 |
2024-07-29 | Walter Matthew R. | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 56364 | 80 |
2024-07-29 | Walter Matthew R. | SVP, Chief HR Officer | A - A-Award | Ordinary Shares | 7625 | 0 |
2024-07-29 | Walter Matthew R. | SVP, Chief HR Officer | A - A-Award | Performance Share Unit | 19063 | 0 |
2024-07-29 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Stock Option (Right to Buy) | 106260 | 80 |
2024-07-29 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Ordinary Shares | 14375 | 0 |
2024-07-29 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Performance Share Unit | 35938 | 0 |
2024-07-29 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Stock Option (Right to Buy) | 106260 | 80 |
2024-07-29 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Ordinary Shares | 14375 | 0 |
2024-07-29 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Performance Share Unit | 35938 | 0 |
2024-07-29 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Stock Option (Right to Buy) | 106260 | 80 |
2024-07-29 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Ordinary Shares | 14375 | 0 |
2024-07-29 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Performance Share Unit | 35938 | 0 |
2024-07-29 | Martha Geoffrey | Chairman and CEO | A - A-Award | Stock Option (Right to Buy) | 295680 | 80 |
2024-07-29 | Martha Geoffrey | Chairman and CEO | A - A-Award | Ordinary Shares | 40000 | 0 |
2024-07-29 | Martha Geoffrey | Chairman and CEO | A - A-Award | Performance Share Unit | 100000 | 0 |
2024-07-29 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Stock Option (Right to Buy) | 101640 | 80 |
2024-07-29 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Ordinary Shares | 13750 | 0 |
2024-07-29 | Marinaro Michael | EVP & President, Surgical OU | D - M-Exempt | Performance Share Unit | 34375 | 0 |
2024-07-29 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 94248 | 80 |
2024-07-29 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Ordinary Shares | 12750 | 0 |
2024-07-29 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Performance Share Unit | 31875 | 0 |
2024-07-29 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 6326 | 0 |
2024-07-29 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 7813 | 0 |
2024-07-29 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Performance Share Unit | 7813 | 0 |
2024-07-29 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Performance Share Unit | 3125 | 0 |
2024-07-29 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 1540 | 80 |
2024-07-18 | Walter Matthew R. | SVP, Chief HR Officer | A - M-Exempt | Ordinary Shares | 492 | 62.76 |
2024-07-18 | Walter Matthew R. | SVP, Chief HR Officer | D - M-Exempt | Stock Option (Right to Buy) | 492 | 62.76 |
2024-06-24 | Walter Matthew R. | SVP, Chief HR Officer | D - | Ordinary Shares | 0 | 0 |
2022-08-02 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 6944 | 131.26 |
2023-08-01 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 9908 | 93.08 |
2024-07-31 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 24525 | 87.76 |
2024-06-24 | Walter Matthew R. | SVP, Chief HR Officer | D - | Performance Share Unit | 8449 | 0 |
2015-07-28 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 492 | 62.76 |
2016-01-27 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 1337 | 74.84 |
2016-08-03 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 1283 | 78 |
2017-08-01 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 1704 | 88.06 |
2018-07-31 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 1787 | 83.97 |
2019-07-30 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 2542 | 89.08 |
2019-10-29 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 191 | 89.45 |
2020-07-29 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 5330 | 103.26 |
2021-08-03 | Walter Matthew R. | SVP, Chief HR Officer | D - | Stock Option (Right to Buy) | 7652 | 97.33 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | A - M-Exempt | Ordinary Shares | 1594 | 62.76 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | A - M-Exempt | Ordinary Shares | 17519 | 62.76 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | D - S-Sale | Ordinary Shares | 17519 | 83.76 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | D - S-Sale | Ordinary Shares | 1594 | 83.82 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | D - M-Exempt | Stock Option (Right to Buy) | 17519 | 62.76 |
2024-06-07 | Martha Geoffrey | Chairman and CEO | D - M-Exempt | Stock Option (Right to Buy) | 1594 | 62.76 |
2024-05-01 | Powell Kendall J | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | OLEARY DENISE M | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | NABEL ELIZABETH G | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | Lofton Kevin E | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | HOGAN RANDALL J | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | Goldsmith Andrea Jo | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | Fonseca Lidia | director | D - F-InKind | Ordinary Shares | 162 | 80.89 |
2024-05-01 | DONNELLY SCOTT C | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-05-01 | ARNOLD CRAIG | director | D - F-InKind | Ordinary Shares | 192 | 80.89 |
2024-04-29 | Powell Kendall J | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | OLEARY DENISE M | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | NABEL ELIZABETH G | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | Lofton Kevin E | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | Lewis Gregory P | director | A - A-Award | Ordinary Shares | 1821 | 80.86 |
2024-04-29 | HOGAN RANDALL J | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | Goldsmith Andrea Jo | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | Fonseca Lidia | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | DONNELLY SCOTT C | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-29 | ARNOLD CRAIG | director | A - A-Award | Ordinary Shares | 2165 | 80.86 |
2024-04-08 | Marinaro Michael | EVP & President, Surgical OU | D - S-Sale | Ordinary Shares | 854 | 83.14 |
2024-03-05 | Marinaro Michael | EVP & President, Surgical OU | D - F-InKind | Ordinary Shares | 563 | 83.6 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | A - M-Exempt | Ordinary Shares | 16035 | 74.84 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - S-Sale | Ordinary Shares | 1594 | 85.06 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - S-Sale | Ordinary Shares | 13066 | 85.15 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | A - M-Exempt | Ordinary Shares | 13066 | 62.76 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | A - M-Exempt | Ordinary Shares | 1594 | 62.76 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - S-Sale | Ordinary Shares | 16035 | 85.12 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - M-Exempt | Stock Option (Right to Buy) | 1594 | 62.76 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - M-Exempt | Stock Option (Right to Buy) | 13066 | 62.76 |
2024-02-21 | Salmon Sean | EVP & President Cardiovascular | D - M-Exempt | Stock Option (Right to Buy) | 16035 | 74.84 |
2024-02-01 | Kirk Jennifer M | Chief Accounting Officer | D - F-InKind | Ordinary Shares | 1159 | 88.09 |
2023-12-19 | Wall Brett A. | EVP & Pres Neuroscience | D - S-Sale | Ordinary Shares | 4997 | 82.17 |
2023-12-08 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - F-InKind | Ordinary Shares | 369 | 79.27 |
2023-12-08 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 435 | 79.27 |
2023-12-08 | Salmon Sean | EVP & President Cardiovascular | D - F-InKind | Ordinary Shares | 435 | 79.27 |
2023-12-08 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | D - F-InKind | Ordinary Shares | 716 | 79.27 |
2023-12-11 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | D - F-InKind | Ordinary Shares | 1952 | 79.35 |
2023-10-30 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 1695 | 69.97 |
2023-08-23 | Smith Gregory L | EVP Global Ops & Supply Chain | D - S-Sale | Ordinary Shares | 10000 | 83.84 |
2023-08-14 | Wall Brett A. | EVP & Pres Neuroscience | D - S-Sale | Ordinary Shares | 1000 | 83.38 |
2023-08-03 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Ordinary Shares | 1696 | 0 |
2023-08-03 | Marinaro Michael | EVP & President, Surgical OU | D - F-InKind | Ordinary Shares | 1323 | 84.49 |
2023-08-04 | Marinaro Michael | EVP & President, Surgical OU | D - S-Sale | Ordinary Shares | 1352 | 84.11 |
2023-08-03 | Marinaro Michael | EVP & President, Surgical OU | D - M-Exempt | Performance Share Unit | 1696 | 0 |
2023-08-03 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 1178 | 0 |
2023-08-03 | Kirk Jennifer M | Chief Accounting Officer | D - F-InKind | Ordinary Shares | 361 | 84.49 |
2023-08-03 | Kirk Jennifer M | Chief Accounting Officer | D - M-Exempt | Performance Share Units | 1178 | 0 |
2023-08-03 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Ordinary Shares | 5813 | 0 |
2023-08-03 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - F-InKind | Ordinary Shares | 4065 | 84.49 |
2023-08-03 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - M-Exempt | Performance Share Units | 5813 | 0 |
2023-08-03 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Ordinary Shares | 5168 | 0 |
2023-08-03 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 4284 | 84.49 |
2023-08-03 | Wall Brett A. | EVP & Pres Neuroscience | D - M-Exempt | Performance Share Units | 5168 | 0 |
2023-08-03 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - A-Award | Ordinary Shares | 4251 | 0 |
2023-08-03 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - F-InKind | Ordinary Shares | 4051 | 84.49 |
2023-08-03 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - M-Exempt | Performance Share Units | 4251 | 0 |
2023-08-03 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Ordinary Shares | 6217 | 0 |
2023-08-03 | Smith Gregory L | EVP Global Ops & Supply Chain | D - F-InKind | Ordinary Shares | 4693 | 84.49 |
2023-08-03 | Smith Gregory L | EVP Global Ops & Supply Chain | D - M-Exempt | Performance Share Units | 6217 | 0 |
2023-08-03 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Ordinary Shares | 5604 | 0 |
2023-08-03 | Salmon Sean | EVP & President Cardiovascular | D - F-InKind | Ordinary Shares | 4369 | 84.49 |
2023-08-03 | Salmon Sean | EVP & President Cardiovascular | D - M-Exempt | Performance Share Units | 5604 | 0 |
2023-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Ordinary Shares | 7105 | 0 |
2023-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - F-InKind | Ordinary Shares | 5919 | 84.49 |
2023-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - M-Exempt | Performance Share Units | 7105 | 0 |
2023-08-03 | Martha Geoffrey | Chairman and CEO | A - A-Award | Ordinary Shares | 18165 | 0 |
2023-08-03 | Martha Geoffrey | Chairman and CEO | D - F-InKind | Ordinary Shares | 17965 | 84.49 |
2023-08-03 | Martha Geoffrey | Chairman and CEO | D - M-Exempt | Performance Share Units | 18165 | 0 |
2023-07-31 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 20058 | 87.76 |
2023-07-31 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 2849 | 0 |
2023-07-31 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Performance Share Units | 7122 | 0 |
2023-07-31 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Stock Option (Right to Buy) | 64185 | 87.76 |
2023-07-31 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Ordinary Shares | 9116 | 0 |
2023-07-31 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Performance Share Units | 22790 | 0 |
2023-07-31 | Wall Brett A. | EVP & Pres Neuroscience | A - M-Exempt | Stock Option (Right to Buy) | 68196 | 87.76 |
2023-07-31 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Ordinary Shares | 9686 | 0 |
2023-07-31 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Performance Share Units | 24214 | 0 |
2023-07-31 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - A-Award | Stock Option (Right to Buy) | 60173 | 87.76 |
2023-07-31 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - A-Award | Ordinary Shares | 8547 | 0 |
2023-07-31 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - A-Award | Performance Share Units | 21366 | 0 |
2023-07-31 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Stock Option (Right to Buy) | 64185 | 87.76 |
2023-07-31 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Ordinary Shares | 26209 | 0 |
2023-07-31 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Performance Share Units | 22790 | 0 |
2023-07-31 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Stock Option (Right to Buy) | 68196 | 87.76 |
2023-07-31 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Ordinary Shares | 9686 | 0 |
2023-07-31 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Performance Share Units | 21214 | 0 |
2023-07-31 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Stock Option (Right to Buy) | 48139 | 87.76 |
2023-07-31 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Ordinary Shares | 6837 | 0 |
2023-07-31 | Marinaro Michael | EVP & President, Surgical OU | A - A-Award | Performance Share Units | 17093 | 0 |
2023-07-31 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 56162 | 87.76 |
2023-07-31 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Ordinary Shares | 7977 | 0 |
2023-07-31 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Performance Share Units | 19941 | 0 |
2023-07-31 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 88254 | 87.76 |
2023-07-31 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Ordinary Shares | 12535 | 0 |
2023-07-31 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Performance Share Units | 31336 | 0 |
2023-07-31 | Martha Geoffrey | Chairman and CEO | A - A-Award | Stock Option (Right to Buy) | 240691 | 87.76 |
2023-07-31 | Martha Geoffrey | Chairman and CEO | A - A-Award | Ordinary Shares | 34185 | 0 |
2023-07-31 | Martha Geoffrey | Chairman and CEO | A - A-Award | Performance Share Units | 85461 | 0 |
2023-07-14 | Wall Brett A. | EVP & Pres Neuroscience | D - S-Sale | Ordinary Shares | 2000 | 87.97 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - M-Exempt | Ordinary Shares | 3706 | 55.32 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - M-Exempt | Ordinary Shares | 1808 | 55.32 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - S-Sale | Ordinary Shares | 1808 | 86.59 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - S-Sale | Ordinary Shares | 3706 | 86.58 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - M-Exempt | Stock Option (Right to Buy) | 1808 | 55.32 |
2023-07-10 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - M-Exempt | Stock Option (Right to Buy) | 3706 | 55.32 |
2023-06-26 | Marinaro Michael | EVP & President, Surgical OU | D - | Ordinary Shares | 0 | 0 |
2023-06-26 | Marinaro Michael | EVP & President, Surgical OU | D - | Performance Share Unit | 8058 | 0 |
2019-07-30 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 6271 | 89.08 |
2016-01-27 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 2345 | 74.84 |
2016-08-03 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 3126 | 78 |
2017-08-01 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 5736 | 88.06 |
2018-05-01 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 4777 | 83.74 |
2018-07-31 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 4407 | 83.97 |
2019-10-29 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 7399 | 89.45 |
2020-07-29 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 22967 | 103.26 |
2021-08-03 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 42192 | 97.33 |
2022-08-02 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 15406 | 131.26 |
2023-08-01 | Marinaro Michael | EVP & President, Surgical OU | D - | Stock Option (Right to Buy) | 26890 | 93.08 |
2023-06-26 | Lewis Gregory P | director | D - | Ordinary Shares | 0 | 0 |
2023-05-01 | OLEARY DENISE M | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | OLEARY DENISE M | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | Powell Kendall J | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | Powell Kendall J | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | Lofton Kevin E | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | Lofton Kevin E | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | Fonseca Lidia | director | A - A-Award | Ordinary Shares | 1624 | 90.68 |
2023-05-01 | DONNELLY SCOTT C | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | DONNELLY SCOTT C | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | ARNOLD CRAIG | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | ARNOLD CRAIG | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | HOGAN RANDALL J | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | HOGAN RANDALL J | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | Goldsmith Andrea Jo | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | Goldsmith Andrea Jo | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | ANDERSON RICHARD H | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | ANDERSON RICHARD H | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-05-01 | NABEL ELIZABETH G | director | A - A-Award | Ordinary Shares | 1930 | 90.68 |
2023-05-02 | NABEL ELIZABETH G | director | D - F-InKind | Ordinary Shares | 169 | 90.23 |
2023-04-18 | Smith Gregory L | EVP Global Ops & Supply Chain | D - F-InKind | Ordinary Shares | 74 | 80.71 |
2023-04-05 | Smith Gregory L | EVP Global Ops & Supply Chain | D - F-InKind | Ordinary Shares | 6866 | 80.27 |
2023-02-01 | Kirk Jennifer M | Chief Accounting Officer | D - F-InKind | Ordinary Shares | 672 | 85.77 |
2022-12-13 | Salmon Sean | EVP & President Cardiovascular | A - M-Exempt | Ordinary Shares | 14823 | 55.32 |
2022-12-13 | Salmon Sean | EVP & President Cardiovascular | A - M-Exempt | Ordinary Shares | 1808 | 55.32 |
2022-12-13 | Salmon Sean | EVP & President Cardiovascular | D - S-Sale | Ordinary Shares | 16631 | 80.4964 |
2022-12-13 | Salmon Sean | EVP & President Cardiovascular | D - M-Exempt | Stock Option (Right to Buy) | 14823 | 0 |
2022-12-09 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | D - F-InKind | Ordinary Shares | 5206 | 78.59 |
2022-12-07 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - F-InKind | Ordinary Shares | 348 | 79.04 |
2022-12-07 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 337 | 79.04 |
2022-12-07 | Salmon Sean | EVP & President Cardiovascular | D - F-InKind | Ordinary Shares | 300 | 79.04 |
2022-10-14 | TEN HOEDT ROB | EVP and Pres. Global Regions | A - M-Exempt | Ordinary Shares | 2404 | 41.6 |
2022-10-14 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - S-Sale | Ordinary Shares | 2404 | 81.537 |
2022-10-14 | TEN HOEDT ROB | EVP and Pres. Global Regions | D - M-Exempt | Stock Option (Right to Buy) | 2404 | 0 |
2022-08-01 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Stock Option (Right to Buy) | 44151 | 93.08 |
2022-08-01 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Ordinary Shares | 5587 | 0 |
2022-08-01 | Smith Gregory L | EVP Global Ops & Supply Chain | A - A-Award | Performance Share Units | 13967 | 0 |
2022-08-01 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Stock Option (Right to Buy) | 59433 | 93.08 |
2022-08-01 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Ordinary Shares | 7521 | 0 |
2022-08-01 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Performance Share Units | 18802 | 0 |
2022-08-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 57735 | 93.08 |
2022-08-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Ordinary Shares | 7306 | 0 |
2022-08-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Performance Share Units | 18264 | 0 |
2022-08-01 | Salmon Sean | EVP & President Cardiovascular | A - A-Award | Ordinary Shares | 8595 | 0 |
2022-08-01 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 18679 | 93.08 |
2022-08-01 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 2364 | 0 |
2022-08-01 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Performance Share Units | 5909 | 0 |
2022-08-01 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 1416 | 93.08 |
2022-08-01 | Surface Carol A | EVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 40754 | 93.08 |
2022-08-01 | Surface Carol A | EVP, Chief HR Officer | A - A-Award | Ordinary Shares | 5157 | 0 |
2022-08-01 | Surface Carol A | EVP, Chief HR Officer | A - A-Award | Performance Share Units | 12893 | 0 |
2022-08-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 54849 | 0 |
2022-08-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 54849 | 93.08 |
2022-08-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Ordinary Shares | 6941 | 0 |
2022-08-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Performance Share Units | 17351 | 0 |
2022-08-01 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Stock Option (Right to Buy) | 67924 | 93.08 |
2022-08-01 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Ordinary Shares | 8595 | 0 |
2022-08-01 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Performance Share Units | 21487 | 0 |
2022-08-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 84905 | 0 |
2022-08-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 84905 | 93.08 |
2022-08-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Ordinary Shares | 10744 | 0 |
2022-08-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Performance Share Units | 26859 | 0 |
2022-08-01 | Martha Geoffrey | Chairman and CEO | A - A-Award | Stock Option (Right to Buy) | 224996 | 0 |
2022-07-29 | Wall Brett A. | EVP & Pres Neuroscience | D - D-Return | Ordinary Shares | 7493 | 0 |
2022-07-29 | TEN HOEDT ROB | EVP & President EMEA | D - D-Return | Ordinary Shares | 9641 | 0 |
2022-07-29 | Liddicoat John R | EVP & President of Americas | D - D-Return | Ordinary Shares | 6543 | 0 |
2022-07-29 | Salmon Sean | EVP & President Cardiovascular | D - D-Return | Ordinary Shares | 5808 | 0 |
2022-07-29 | Surface Carol A | EVP, Chief HR Officer | D - D-Return | Ordinary Shares | 7920 | 0 |
2022-07-29 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - D-Return | Ordinary Shares | 12397 | 0 |
2022-07-29 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - D-Return | Ordinary Shares | 15151 | 0 |
2022-07-29 | Martha Geoffrey | Chairman and CEO | D - D-Return | Ordinary Shares | 23410 | 0 |
2022-06-27 | Smith Gregory L | EVP Global Ops & Supply Chain | D - | Ordinary Shares | 0 | 0 |
2022-06-27 | Smith Gregory L | EVP Global Ops & Supply Chain | D - | Performance Share Units | 8762 | 0 |
2022-04-05 | Smith Gregory L | EVP Global Ops & Supply Chain | D - | Stock Option (Right to Buy) | 30837 | 120.25 |
2022-08-02 | Smith Gregory L | EVP Global Ops & Supply Chain | D - | Stock Option (Right to Buy) | 31028 | 131.26 |
2022-06-27 | Fonseca Lidia | - | 0 | 0 | ||
2022-05-02 | Goldsmith Andrea Jo | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | Goldsmith Andrea Jo | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | ANDERSON RICHARD H | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | ANDERSON RICHARD H | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | Powell Kendall J | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | Powell Kendall J | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | OLEARY DENISE M | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | OLEARY DENISE M | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | NABEL ELIZABETH G | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | NABEL ELIZABETH G | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | Lofton Kevin E | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | Lofton Kevin E | D - F-InKind | Ordinary Shares | 161 | 103.11 | |
2022-05-02 | HOGAN RANDALL J | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | HOGAN RANDALL J | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | DONNELLY SCOTT C | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | DONNELLY SCOTT C | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-05-02 | ARNOLD CRAIG | A - A-Award | Ordinary Shares | 1697 | 0 | |
2022-05-02 | ARNOLD CRAIG | D - F-InKind | Ordinary Shares | 262 | 103.11 | |
2022-03-18 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 682 | 110 |
2022-03-11 | Surface Carol A | SVP, Chief HR Officer | D - S-Sale | Ordinary Shares | 6000 | 105.3 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 145852 | 103.59 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Stock Option (Right to Buy) | 50476 | 103.59 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Ordinary Shares | 24134 | 0 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Performance Share Units | 21238 | 0 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Performance Share Units | 15591 | 0 |
2022-02-01 | Fong Ivan K | EVP GENERAL COUNSEL & SECR | A - A-Award | Ordinary Shares | 6237 | 0 |
2022-02-01 | Fong Ivan K | officer | - | 0 | 0 | |
2022-02-01 | Kirk Jennifer M | Chief Accounting Officer | D - F-InKind | Ordinary Shares | 636 | 103.59 |
2021-12-23 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - S-Sale | Ordinary Shares | 7218 | 102.04 |
2021-12-16 | ANDERSON RICHARD H | director | A - P-Purchase | Ordinary Shares | 5010 | 103.26 |
2021-12-15 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - F-InKind | Ordinary Shares | 89 | 104.94 |
2021-12-06 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - G-Gift | Ordinary Shares | 49859 | 0 |
2021-12-06 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 682 | 110 |
2021-12-06 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 49859 | 0 |
2021-11-05 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - F-InKind | Ordinary Shares | 246 | 122.98 |
2021-11-05 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 238 | 122.98 |
2021-11-05 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - F-InKind | Ordinary Shares | 245 | 122.98 |
2021-11-05 | Liddicoat John R | EVP & President of Americas | D - F-InKind | Ordinary Shares | 139 | 122.98 |
2021-11-05 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - F-InKind | Ordinary Shares | 250 | 122.98 |
2021-11-05 | Kuntz Richard | SVP & Chief Medical & Science | D - F-InKind | Ordinary Shares | 209 | 122.98 |
2021-11-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Ordinary Shares | 832 | 0 |
2021-11-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 6670 | 120.23 |
2021-11-01 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Performance Share Units | 2080 | 0 |
2021-10-08 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - G-Gift | Ordinary Shares | 12000 | 0 |
2021-10-06 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 37859 | 0 |
2021-10-06 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - G-Gift | Ordinary Shares | 37859 | 0 |
2021-10-08 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 12000 | 0 |
2021-09-30 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 49147 | 78 |
2021-09-30 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 49147 | 126.58 |
2021-09-30 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - M-Exempt | Stock Option (Right to Buy) | 49147 | 78 |
2021-08-31 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 50775 | 74.84 |
2021-08-31 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 50775 | 134.17 |
2021-08-31 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - M-Exempt | Stock Option (Right to Buy) | 50775 | 74.84 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - M-Exempt | Ordinary Shares | 21129 | 38.81 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - M-Exempt | Ordinary Shares | 4713 | 38.2 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - M-Exempt | Ordinary Shares | 2577 | 38.81 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - S-Sale | Ordinary Shares | 21129 | 134.08 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - S-Sale | Ordinary Shares | 21129 | 134.08 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - M-Exempt | Stock Option (Right to Buy) | 4713 | 38.2 |
2021-08-25 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - M-Exempt | Stock Option (Right to Buy) | 2577 | 38.81 |
2021-08-25 | Martha Geoffrey | CEO | A - M-Exempt | Ordinary Shares | 10100 | 62.76 |
2021-08-25 | Martha Geoffrey | CEO | A - M-Exempt | Ordinary Shares | 1481 | 55.32 |
2021-08-25 | Martha Geoffrey | CEO | D - S-Sale | Ordinary Shares | 10100 | 132.67 |
2021-08-25 | Martha Geoffrey | CEO | D - M-Exempt | Stock Option (Right to Buy) | 10100 | 62.76 |
2021-08-25 | Martha Geoffrey | CEO | D - M-Exempt | Stock Option (Right to Buy) | 1481 | 55.32 |
2021-08-02 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Stock Option (Right to Buy) | 52074 | 131.26 |
2021-08-02 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Ordinary Shares | 6095 | 0 |
2021-08-02 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - F-InKind | Ordinary Shares | 4897 | 131.31 |
2021-08-02 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Performance Share Units | 15237 | 0 |
2021-08-02 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Stock Option (Right to Buy) | 45565 | 131.26 |
2021-08-02 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Ordinary Shares | 5333 | 0 |
2021-08-02 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 1482 | 131.31 |
2021-08-02 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Performance Share Units | 13333 | 0 |
2021-08-02 | Wall Brett A. | EVP & Pres Neuroscience | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Ordinary Shares | 4419 | 0 |
2021-08-02 | TEN HOEDT ROB | EVP & President EMEA | D - F-InKind | Ordinary Shares | 3908 | 131.31 |
2021-08-02 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 37754 | 131.26 |
2021-08-02 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Performance Share Units | 11047 | 0 |
2021-08-02 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Ordinary Shares | 3657 | 0 |
2021-08-02 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 31245 | 131.26 |
2021-08-02 | Surface Carol A | SVP, Chief HR Officer | D - F-InKind | Ordinary Shares | 3997 | 131.31 |
2021-08-02 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Performance Share Units | 9143 | 0 |
2021-08-02 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - A-Award | Stock Option (Right to Buy) | 46867 | 131.26 |
2021-08-02 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - A-Award | Ordinary Shares | 5486 | 0 |
2021-08-02 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | D - F-InKind | Ordinary Shares | 2272 | 131.31 |
2021-08-02 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - A-Award | Performance Share Units | 13714 | 0 |
2021-08-02 | Salmon Sean | EVP & Pres Diabetes/Cardiovasc | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Ordinary Shares | 7162 | 0 |
2021-08-02 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - F-InKind | Ordinary Shares | 6839 | 131.31 |
2021-08-02 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 61187 | 131.26 |
2021-08-02 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Performance Share Units | 17904 | 0 |
2021-08-02 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Martha Geoffrey | CEO | A - A-Award | Stock Option (Right to Buy) | 162731 | 131.26 |
2021-08-02 | Martha Geoffrey | CEO | A - A-Award | Ordinary Shares | 19047 | 0 |
2021-08-02 | Martha Geoffrey | CEO | D - F-InKind | Ordinary Shares | 5450 | 131.31 |
2021-08-02 | Martha Geoffrey | CEO | A - A-Award | Performance Share Units | 47616 | 0 |
2021-08-02 | Liddicoat John R | EVP & President of Americas | A - A-Award | Ordinary Shares | 3353 | 0 |
2021-08-02 | Liddicoat John R | EVP & President of Americas | D - F-InKind | Ordinary Shares | 3258 | 131.31 |
2021-08-02 | Liddicoat John R | EVP & President of Americas | A - A-Award | Stock Option (Right to Buy) | 28641 | 131.26 |
2021-08-02 | Liddicoat John R | EVP & President of Americas | A - A-Award | Performance Share Units | 8381 | 0 |
2021-08-02 | Liddicoat John R | EVP & President of Americas | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Stock Option (Right to Buy) | 51423 | 131.26 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Ordinary Shares | 6019 | 0 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 4000 | 131.52 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - F-InKind | Ordinary Shares | 5450 | 131.31 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Performance Share Units | 15047 | 0 |
2021-08-02 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Ordinary Shares | 5029 | 0 |
2021-08-02 | Kuntz Richard | SVP & Chief Medical & Science | D - F-InKind | Ordinary Shares | 4905 | 131.31 |
2021-08-02 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Stock Option (Right to Buy) | 42961 | 131.26 |
2021-08-02 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Performance Share Units | 12571 | 0 |
2021-08-02 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-08-02 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 9764 | 131.26 |
2021-08-02 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Ordinary Shares | 1143 | 0 |
2021-08-02 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Performance Share Units | 2857 | 0 |
2021-08-02 | Kirk Jennifer M | Chief Accounting Officer | A - A-Award | Stock Option (Right to Buy) | 1085 | 131.26 |
2021-06-30 | Kirk Jennifer M | Chief Accounting Officer | D - | Ordinary Shares | 0 | 0 |
2021-06-30 | Kirk Jennifer M | Chief Accounting Officer | D - | Performance Share Units | 3373 | 0 |
2022-02-01 | Kirk Jennifer M | Chief Accounting Officer | D - | Stock Option (Right to Buy) | 11123 | 111.18 |
2021-06-28 | Martha Geoffrey | CEO | A - M-Exempt | Ordinary Shares | 11500 | 55.32 |
2021-06-28 | Martha Geoffrey | CEO | D - S-Sale | Ordinary Shares | 11500 | 125.29 |
2021-06-28 | Martha Geoffrey | CEO | D - M-Exempt | Stock Option (Right to Buy) | 11500 | 55.32 |
2021-06-22 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 238 | 0 |
2021-06-22 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 238 | 0 |
2021-06-22 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 238 | 0 |
2021-06-22 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - G-Gift | Ordinary Shares | 238 | 0 |
2021-06-18 | Wall Brett A. | EVP & Pres Neuroscience | A - M-Exempt | Ordinary Shares | 1168 | 74.84 |
2021-06-18 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 938 | 123.23 |
2021-06-21 | Wall Brett A. | EVP & Pres Neuroscience | D - S-Sale | Ordinary Shares | 115 | 123.5 |
2021-06-18 | Wall Brett A. | EVP & Pres Neuroscience | D - M-Exempt | Stock Option (Right to Buy) | 1168 | 74.84 |
2021-06-15 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 605 | 124.47 |
2021-05-28 | Wall Brett A. | EVP & Pres Neuroscience | A - M-Exempt | Ordinary Shares | 12300 | 47 |
2021-05-28 | Wall Brett A. | EVP & Pres Neuroscience | D - F-InKind | Ordinary Shares | 7355 | 126.59 |
2021-06-01 | Wall Brett A. | EVP & Pres Neuroscience | D - S-Sale | Ordinary Shares | 2473 | 128.07 |
2021-05-28 | Wall Brett A. | EVP & Pres Neuroscience | D - M-Exempt | Stock Option (Right to Buy) | 12300 | 47 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | A - M-Exempt | Ordinary Shares | 15142 | 88.06 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | A - M-Exempt | Ordinary Shares | 1136 | 88.06 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | A - M-Exempt | Ordinary Shares | 1283 | 78 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | A - M-Exempt | Ordinary Shares | 17095 | 78 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | D - S-Sale | Ordinary Shares | 34656 | 126.65 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | D - M-Exempt | Stock Option (Right to Buy) | 1283 | 78 |
2021-05-28 | Liddicoat John R | EVP & President of Americas | D - M-Exempt | Stock Option (Right to Buy) | 15142 | 88.06 |
2021-05-03 | Powell Kendall J | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | OLEARY DENISE M | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | NABEL ELIZABETH G | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | Lofton Kevin E | director | A - A-Award | Ordinary Shares | 820 | 0 |
2021-05-03 | Lenehan James T | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | LEAVITT MICHAEL O | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | HOGAN RANDALL J | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | Goldsmith Andrea Jo | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | DONNELLY SCOTT C | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | ARNOLD CRAIG | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-05-03 | ANDERSON RICHARD H | director | A - A-Award | Ordinary Shares | 1334 | 0 |
2021-04-27 | ANDERSON RICHARD H | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | ARNOLD CRAIG | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | DONNELLY SCOTT C | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | Goldsmith Andrea Jo | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | HOGAN RANDALL J | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | Lenehan James T | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | NABEL ELIZABETH G | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | OLEARY DENISE M | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-27 | Powell Kendall J | director | D - F-InKind | Ordinary Shares | 426 | 129.97 |
2021-04-05 | Martha Geoffrey | CEO | A - M-Exempt | Ordinary Shares | 9308 | 55.32 |
2021-04-05 | Martha Geoffrey | CEO | A - M-Exempt | Ordinary Shares | 2404 | 41.6 |
2021-04-05 | Martha Geoffrey | CEO | D - S-Sale | Ordinary Shares | 9308 | 118.83 |
2021-04-05 | Martha Geoffrey | CEO | D - M-Exempt | Stock Option (Right to Buy) | 9308 | 55.32 |
2021-04-05 | Martha Geoffrey | CEO | D - M-Exempt | Stock Option (Right to Buy) | 2404 | 41.6 |
2021-03-15 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 632 | 119.12 |
2021-03-02 | TEN HOEDT ROB | EVP & President EMEA | A - M-Exempt | Ordinary Shares | 7168 | 34.88 |
2021-03-02 | TEN HOEDT ROB | EVP & President EMEA | D - S-Sale | Ordinary Shares | 7168 | 117.98 |
2021-03-02 | TEN HOEDT ROB | EVP & President EMEA | D - M-Exempt | Stock Option (Right to Buy) | 7168 | 34.88 |
2021-02-01 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Ordinary Shares | 1979 | 0 |
2021-02-01 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Stock Option (Right to Buy) | 16314 | 111.18 |
2021-02-01 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Performance Share Units | 4947 | 0 |
2020-12-28 | Surface Carol A | SVP, Chief HR Officer | D - S-Sale | Ordinary Shares | 15000 | 114.9 |
2020-12-22 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 2605 | 115.56 |
2020-12-16 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - G-Gift | Ordinary Shares | 1500 | 0 |
2020-12-18 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | D - S-Sale | Ordinary Shares | 10930 | 115.46 |
2020-12-16 | WHITE ROBERT JOHN | EVP & Pres. Medical Surgical | A - G-Gift | Ordinary Shares | 1500 | 0 |
2020-12-15 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 670 | 114.33 |
2020-10-15 | ISHRAK OMAR | Executive Chairman | D - G-Gift | Ordinary Shares | 8650 | 0 |
2020-10-15 | ISHRAK OMAR | Executive Chairman | A - G-Gift | Ordinary Shares | 8650 | 0 |
2020-10-14 | HOGAN RANDALL J | director | A - G-Gift | Ordinary Shares | 36798 | 0 |
2020-10-14 | HOGAN RANDALL J | director | D - G-Gift | Ordinary Shares | 36798 | 0 |
2020-11-09 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 797 | 62.76 |
2020-11-09 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 19918 | 62.76 |
2020-11-09 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 20715 | 113.13 |
2020-11-09 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - M-Exempt | Stock Option (Right to Buy) | 797 | 62.76 |
2020-11-03 | WHITE ROBERT JOHN | EVP & President MITG | D - F-InKind | Ordinary Shares | 299 | 103.13 |
2020-11-03 | Wall Brett A. | EVP & Group Pres Restora Thera | D - F-InKind | Ordinary Shares | 229 | 103.13 |
2020-11-03 | Salmon Sean | EVP & Group President Diabetes | D - F-InKind | Ordinary Shares | 220 | 103.13 |
2020-11-03 | Liddicoat John R | EVP & President of Americas | D - F-InKind | Ordinary Shares | 128 | 103.13 |
2020-11-03 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - F-InKind | Ordinary Shares | 337 | 103.13 |
2020-11-03 | Kuntz Richard | SVP & Chief Medical & Science | D - F-InKind | Ordinary Shares | 273 | 103.13 |
2020-11-03 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - F-InKind | Ordinary Shares | 393 | 103.13 |
2020-10-09 | WHITE ROBERT JOHN | EVP & President MITG | A - A-Award | Performance Share Units | 16563 | 0 |
2020-10-09 | Wall Brett A. | EVP & Group Pres Restora Thera | A - A-Award | Performance Share Units | 14723 | 0 |
2020-10-09 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Performance Share Units | 12882 | 0 |
2020-10-09 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Performance Share Units | 10582 | 0 |
2020-10-09 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Performance Share Units | 11042 | 0 |
2020-10-09 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Performance Share Units | 20243 | 0 |
2020-10-09 | Martha Geoffrey | CEO | A - A-Award | Performance Share Units | 51758 | 0 |
2020-10-09 | Liddicoat John R | EVP & President of Americas | A - A-Award | Performance Share Units | 8742 | 0 |
2020-10-09 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Performance Share Units | 18173 | 0 |
2020-10-09 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Performance Share Units | 14723 | 0 |
2020-10-09 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - A-Award | Performance Share Units | 21164 | 0 |
2020-10-09 | ISHRAK OMAR | Executive Chairman | A - G-Gift | Ordinary Shares | 5900 | 0 |
2020-10-09 | ISHRAK OMAR | Executive Chairman | D - S-Sale | Ordinary Shares | 763 | 108.4 |
2020-10-09 | ISHRAK OMAR | Executive Chairman | D - G-Gift | Ordinary Shares | 5900 | 0 |
2020-10-08 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 19917 | 62.76 |
2020-10-08 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - M-Exempt | Ordinary Shares | 797 | 62.76 |
2020-10-08 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - S-Sale | Ordinary Shares | 797 | 110 |
2020-10-08 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - M-Exempt | Stock Option (Right to Buy) | 19917 | 62.76 |
2020-10-08 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - M-Exempt | Stock Option (Right to Buy) | 797 | 62.76 |
2020-10-08 | ANDERSON RICHARD H | director | A - P-Purchase | Ordinary Shares | 4607 | 108.52 |
2020-09-23 | TEN HOEDT ROB | EVP & President EMEA | D - S-Sale | Ordinary Shares | 9584 | 104.34 |
2020-09-15 | Lofton Kevin E | - | 0 | 0 | ||
2020-09-15 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - S-Sale | Ordinary Shares | 702 | 107.78 |
2020-09-09 | TEN HOEDT ROB | EVP & President EMEA | D - S-Sale | Ordinary Shares | 9563 | 105.05 |
2020-08-03 | WHITE ROBERT JOHN | EVP & President MITG | A - A-Award | Stock Option (Right to Buy) | 68010 | 97.33 |
2020-08-03 | WHITE ROBERT JOHN | EVP & President MITG | A - A-Award | Ordinary Shares | 7398 | 0 |
2020-08-03 | WHITE ROBERT JOHN | EVP & President MITG | A - A-Award | Stock Option (Right to Buy) | 40302 | 97.33 |
2020-08-03 | WHITE ROBERT JOHN | EVP & President MITG | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | A - A-Award | Stock Option (Right to Buy) | 60453 | 97.33 |
2020-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | A - A-Award | Stock Option (Right to Buy) | 23930 | 97.33 |
2020-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | A - A-Award | Ordinary Shares | 6576 | 0 |
2020-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Ordinary Shares | 5754 | 0 |
2020-08-03 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 52896 | 97.33 |
2020-08-03 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 42191 | 97.33 |
2020-08-03 | TEN HOEDT ROB | EVP & President EMEA | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Ordinary Shares | 4727 | 0 |
2020-08-03 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 43451 | 97.33 |
2020-08-03 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 34005 | 97.33 |
2020-08-03 | Surface Carol A | SVP, Chief HR Officer | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Stock Option (Right to Buy) | 45340 | 97.33 |
2020-08-03 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Stock Option (Right to Buy) | 30227 | 97.33 |
2020-08-03 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Ordinary Shares | 4932 | 0 |
2020-08-03 | Salmon Sean | EVP & Group President Diabetes | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Ordinary Shares | 9042 | 0 |
2020-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 83123 | 97.33 |
2020-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 50378 | 97.33 |
2020-08-03 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Martha Geoffrey | CEO | A - A-Award | Stock Option (Right to Buy) | 212529 | 97.33 |
2020-08-03 | Martha Geoffrey | CEO | A - A-Award | Ordinary Shares | 23118 | 0 |
2020-08-03 | Martha Geoffrey | CEO | A - A-Award | Stock Option (Right to Buy) | 71158 | 97.33 |
2020-08-03 | Liddicoat John R | EVP & President of Americas | A - A-Award | Ordinary Shares | 3905 | 0 |
2020-08-03 | Liddicoat John R | EVP & President of Americas | A - A-Award | Stock Option (Right to Buy) | 39672 | 97.33 |
2020-08-03 | Liddicoat John R | EVP & President of Americas | A - A-Award | Stock Option (Right to Buy) | 35894 | 97.33 |
2020-08-03 | Liddicoat John R | EVP & President of Americas | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Stock Option (Right to Buy) | 74622 | 97.33 |
2020-08-03 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Ordinary Shares | 8117 | 0 |
2020-08-03 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Stock Option (Right to Buy) | 39043 | 97.33 |
2020-08-03 | Lerman Bradley E | SVP General Counsel & Corp Sec | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Ordinary Shares | 6576 | 0 |
2020-08-03 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Stock Option (Right to Buy) | 60453 | 97.33 |
2020-08-03 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Stock Option (Right to Buy) | 36524 | 97.33 |
2020-08-03 | Kuntz Richard | SVP & Chief Medical & Science | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-08-03 | ISHRAK OMAR | Executive Chairman | A - A-Award | Stock Option (Right to Buy) | 159318 | 97.33 |
2020-08-03 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - A-Award | Ordinary Shares | 9453 | 0 |
2020-08-03 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - A-Award | Stock Option (Right to Buy) | 86901 | 97.33 |
2020-08-03 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - A-Award | Stock Option (Right to Buy) | 49118 | 97.33 |
2020-08-03 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - A-Award | Stock Option (Right to Buy) | 1575 | 97.33 |
2020-07-31 | WHITE ROBERT JOHN | EVP & President MITG | D - F-InKind | Ordinary Shares | 2727 | 96.48 |
2020-07-31 | Wall Brett A. | EVP & Group Pres Restora Thera | D - F-InKind | Ordinary Shares | 1100 | 96.48 |
2020-07-31 | TEN HOEDT ROB | EVP & President EMEA | D - F-InKind | Ordinary Shares | 3677 | 96.48 |
2020-07-31 | Surface Carol A | SVP, Chief HR Officer | D - F-InKind | Ordinary Shares | 3554 | 96.48 |
2020-07-31 | Salmon Sean | EVP & Group President Diabetes | D - F-InKind | Ordinary Shares | 2569 | 96.48 |
2020-07-31 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - F-InKind | Ordinary Shares | 6339 | 96.48 |
2020-07-31 | Martha Geoffrey | CEO | D - F-InKind | Ordinary Shares | 4252 | 96.48 |
2020-07-31 | Liddicoat John R | EVP & President of Americas | D - F-InKind | Ordinary Shares | 2269 | 96.48 |
2020-07-31 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - F-InKind | Ordinary Shares | 5411 | 96.48 |
2020-07-31 | Kuntz Richard | SVP & Chief Medical & Science | D - F-InKind | Ordinary Shares | 4482 | 96.48 |
2020-07-31 | ISHRAK OMAR | Executive Chairman | D - F-InKind | Ordinary Shares | 26082 | 96.48 |
2020-07-31 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - F-InKind | Ordinary Shares | 7922 | 96.48 |
2020-06-30 | ISHRAK OMAR | Executive Chairman | D - G-Gift | Ordinary Shares | 22508 | 0 |
2020-06-30 | ISHRAK OMAR | Executive Chairman | A - G-Gift | Ordinary Shares | 22508 | 0 |
2020-06-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 305 | 0 |
2020-06-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 305 | 0 |
2020-06-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | D - G-Gift | Ordinary Shares | 305 | 0 |
2020-06-01 | PARKHILL KAREN L | EVP & Chief Financial Officer | A - G-Gift | Ordinary Shares | 305 | 0 |
2020-05-29 | Surface Carol A | SVP, Chief HR Officer | D - S-Sale | Ordinary Shares | 2000 | 97.72 |
2020-04-29 | Powell Kendall J | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | OLEARY DENISE M | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | NABEL ELIZABETH G | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | Lenehan James T | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | HOGAN RANDALL J | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | Goldsmith Andrea Jo | director | D - F-InKind | Ordinary Shares | 51 | 99.14 |
2020-04-29 | DONNELLY SCOTT C | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | ARNOLD CRAIG | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-29 | ANDERSON RICHARD H | director | D - F-InKind | Ordinary Shares | 393 | 99.14 |
2020-04-27 | Powell Kendall J | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | OLEARY DENISE M | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | NABEL ELIZABETH G | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | Lenehan James T | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | LEAVITT MICHAEL O | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | HOGAN RANDALL J | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | Goldsmith Andrea Jo | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | DONNELLY SCOTT C | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | ARNOLD CRAIG | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-27 | ANDERSON RICHARD H | director | A - A-Award | Ordinary Shares | 1737 | 0 |
2020-04-03 | OLEARY DENISE M | director | A - M-Exempt | Ordinary Shares | 1813 | 44.13 |
2020-04-03 | OLEARY DENISE M | director | D - F-InKind | Ordinary Shares | 929 | 86.27 |
2020-04-03 | OLEARY DENISE M | director | D - M-Exempt | Stock Option (Right to Buy) | 1813 | 44.13 |
2020-02-20 | ISHRAK OMAR | Chairman & CEO | A - P-Purchase | Ordinary Shares | 8771 | 113.68 |
2019-11-01 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Ordinary Shares | 0 | 0 |
2016-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1283 | 78 |
2020-10-28 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 22579 | 106.22 |
2017-08-01 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1136 | 88.06 |
2018-07-31 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1191 | 83.97 |
2019-07-30 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1695 | 89.08 |
2020-07-29 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1615 | 103.26 |
2014-12-02 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 12300 | 47 |
2018-06-29 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 8018 | 74.84 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | A - M-Exempt | Ordinary Shares | 38558 | 55.32 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - S-Sale | Ordinary Shares | 5067 | 113.64 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | A - M-Exempt | Ordinary Shares | 2404 | 41.6 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | A - M-Exempt | Ordinary Shares | 1808 | 55.32 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - S-Sale | Ordinary Shares | 1808 | 113.66 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - S-Sale | Ordinary Shares | 3019 | 113.63 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - S-Sale | Ordinary Shares | 2404 | 113.6 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - S-Sale | Ordinary Shares | 38558 | 113.56 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - M-Exempt | Stock Option (Right to Buy) | 2404 | 41.6 |
2019-12-24 | Kuntz Richard | SVP & Chief Medical & Science | D - M-Exempt | Stock Option (Right to Buy) | 38558 | 55.32 |
2019-12-18 | Lerman Bradley E | SVP General Counsel & Corp Sec | D - G-Gift | Ordinary Shares | 2275 | 0 |
2019-12-03 | ISHRAK OMAR | Chairman & CEO | D - G-Gift | Ordinary Shares | 18182 | 0 |
2019-12-03 | ISHRAK OMAR | Chairman & CEO | A - G-Gift | Ordinary Shares | 18182 | 0 |
2019-12-06 | ANDERSON RICHARD H | director | A - P-Purchase | Ordinary Shares | 5000 | 113.29 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | A - M-Exempt | Ordinary Shares | 26724 | 74.84 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - S-Sale | Ordinary Shares | 13484 | 110.285 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - S-Sale | Ordinary Shares | 13240 | 110.973 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | A - M-Exempt | Ordinary Shares | 25442 | 47 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - S-Sale | Ordinary Shares | 12859 | 110.28 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - S-Sale | Ordinary Shares | 12583 | 110.973 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - M-Exempt | Stock Option (Right to Buy) | 25442 | 47 |
2019-12-02 | WHITE ROBERT JOHN | EVP & President MITG | D - M-Exempt | Stock Option (Right to Buy) | 26724 | 74.84 |
2019-11-15 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - M-Exempt | Ordinary Shares | 36874 | 38.81 |
2019-11-15 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - S-Sale | Ordinary Shares | 7367 | 110.585 |
2019-11-15 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - S-Sale | Ordinary Shares | 25710 | 111.314 |
2019-11-15 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - S-Sale | Ordinary Shares | 3797 | 112.07 |
2019-11-15 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - M-Exempt | Stock Option (Right to Buy) | 36874 | 38.81 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - M-Exempt | Ordinary Shares | 1202 | 41.6 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | A - M-Exempt | Ordinary Shares | 900 | 38.81 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - S-Sale | Ordinary Shares | 900 | 109.523 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - S-Sale | Ordinary Shares | 1202 | 109.95 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - M-Exempt | Stock Option (Right to Buy) | 900 | 38.81 |
2019-11-14 | COYLE MICHAEL J | EVP & Group Pres, Cardiac&Vasc | D - M-Exempt | Stock Option (Right to Buy) | 1202 | 41.6 |
2019-11-01 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Ordinary Shares | 0 | 0 |
2014-12-02 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 12300 | 47 |
2018-06-29 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 8018 | 74.84 |
2020-10-28 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 22579 | 106.22 |
2016-08-03 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1283 | 78 |
2017-08-01 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1136 | 88.06 |
2018-07-31 | Wall Brett A. | EVP & Group Pres Restora Thera | D - | Stock Option (Right to Buy) | 1191 | 83.97 |